Abatacept (Orencia): Plattenepithelkarzinome, Hautpapillome, Lymphome und maligne Neoplasmen der Lunge

Last Updated on

20. Oktober 2017 – In Abstimmung mit Swissmedic, dem Schweizerischen Heilmittelinstitut, informiert die Zulassungsinhaberin von Abatacept (Orencia) in der Schweiz, die Bristol-Myers Squibb SA, über Änderungen in der Schweizer Arzneimittelinformation zu Abatacept (Orencia) in der Form einer Direct Healthcare Professional Communication (DHPC).

Plattenepithelkarzinom

Gemäss der Mitteilung wurden nach der Markteinführung (Postmarketing) von Abatacept (Orencia) bei Patienten mit rheumatoider Arthritis, die Abatacept (Orencia) (Abatacept) verwendeten, spontane Fälle von Plattenepithelkarzinomen, Hautpapillomen, Lymphomen und malignen Neoplasmen der Lunge beobachtet. Diese gravierenden unerwünschten Ereignisse werden neu in die Abschnitte “Unerwünschte Wirkungen” und “Warnhinweise und Vorsichtsmassnahmen” der Schweizer Arzneimittelinformation zu Abatacept (Orencia) aufgenommen. Nach Einschätzung von Swissmedic und der Zulassungsinhaberin bleibt das sogenannte Nutzen-Risiko-Profil von Abatacept (Orencia) unverändert. Allen Patienten werden jedoch regelmässige Hautuntersuchungen empfohlen, insbesondere wenn weitere Risikofaktoren für Hautkrebs vorliegen sollten.

Seit der ursprünglichen Markteinführung von Abatacept (Orencia) wurden in der Schweizer Arzneimittelinformation von Abatacept (Orencia) Malignitäten unter “Warnhinweise und Vorsichtsmassnahmen” sowie unter “Unerwünschte Wirkungen” schon beschrieben. Dabei wurde darauf hingewiesen, dass Arzneimittel, die wie Abatacept (Orencia) unterdrückend auf das Immunsystem einwirken, die Immunabwehr gegen Malignitäten insgesamt schwächen können.

Seit der Einführung von sogenannten Checkpoint-Inhibitoren wie Pembrolizumab (Keytruda), Ipilimumab (Yervoy), Nivolumab (Opdivo), und anderen in der erfolgreichen Behandlung von gewissen Tumoren durch eine gezielte Stärkung des lokalen Immunsystems, ist es denkbar, dass eine Schwächung des Immunsystems als Auslöser für das Entstehen gewisser Tumore verantwortlich sein kann. Dies ist der wahrscheinliche Mechanismus des mit Abatacept (Orencia) beobachteten Auftretens der hier beschriebenen Malignitäten, obwohl die Zulassungsinhaberin schreibt, dass trotz umfangreicher präklinischer und klinischer Programme, Beobachtungsstudien, permanenter Überprüfung der medizinischen Literatur und kontinuierlicher Überwachung der Postmarketingberichte es immer noch keine ausreichende Evidenz für einen kausalen Zusammenhang zwischen der Anwendung von Abatacept (Orencia) und dem Auftreten von Malignitäten im Allgemeinen oder speziellen Krebsarten gebe.  Der Zusammenhang könnte jedoch sehr wohl kausal sein; immerhin kennt man von einigen immunosupressiven Arzneimitteln das Auftreten von Plattenepithelkarzinoma als schwerwiegende unerwünschte Nebenwirkung schon lange.

 _______________

Tags: , , , , , ,
About the Author
thassodotcom Professor in Pharmakologie und Toxikologie. Experte in theragenomischer und personalisierter Medizin und individualisierter Arzneimittelsicherheit. Experte in Pharmako- und Toxiko-Genetik. Experte in der klinischen Sicherheit von Arzneimitteln, Chemikalien, Umweltschadstoffen und Nahrungsinhaltsstoffen.

Leave a Reply

Optional: Social Subscribe/Login




avatar
  Subscribe  
Notify of
trackback

pocket pussy

[…]that would be the finish of this article. Right here you’ll obtain some sites that we feel you will value, just click the hyperlinks over[…]

trackback

Google

We prefer to honor several other web web sites on the internet, even if they aren’t linked to us, by linking to them. Beneath are some webpages worth checking out.

trackback

sex lube

[…]always a massive fan of linking to bloggers that I enjoy but really don’t get lots of link love from[…]

trackback

mario kart cartridges

[…]always a large fan of linking to bloggers that I appreciate but do not get lots of link love from[…]

trackback

adam and eve

[…]very handful of internet websites that happen to become detailed below, from our point of view are undoubtedly effectively worth checking out[…]

trackback

618media.com

[…]usually posts some really fascinating stuff like this. If you are new to this site[…]

trackback

Google

Here are a few of the web pages we advocate for our visitors.

minecraft
Guest

I have been surfing online more than 2 hours today, yet I never found any interesting article like yours.
It is pretty worth enough for me. In my opinion, if all web owners and bloggers made good content as you did, the net will be a lot more useful than ever before.

minecraft
Guest

Woah! I’m really digging the template/theme of this blog.
It’s simple, yet effective. A lot of times it’s hard to get that “perfect balance” between superb usability
and visual appeal. I must say you’ve done a excellent job with this.
In addition, the blog loads very fast for me on Opera.
Exceptional Blog!

minecraft
Guest

Hi there i am kavin, its my first occasion to commenting anywhere, when i read this piece of writing i thought
i could also create comment due to this sensible paragraph.

minecraft
Guest

Wow, marvelous blog layout! How long have you been blogging for?
you make blogging look easy. The overall look of your web site is great, as
well as the content!

minecraft
Guest

Howdy I am so grateful I found your site, I really found you by error, while I was looking on Aol
for something else, Anyhow I am here now and would just like to say many thanks for a fantastic post and a all round interesting blog (I also love the theme/design), I don’t have time to go through it all at the moment but I
have book-marked it and also included your RSS feeds, so when I have
time I will be back to read a great deal more, Please
do keep up the superb b.

minecraft
Guest

Hello there, You have done an excellent job. I will definitely
digg it and personally recommend to my friends. I am confident they will
be benefited from this site.

minecraft
Guest

I constantly emailed this web site post page to all my friends, for the reason that if like to read it afterward my links will
too.

minecraft
Guest

Very descriptive article, I enjoyed that a lot. Will there be a part 2?

minecraft
Guest

Hurrah! In the end I got a website from where I can truly obtain valuable facts concerning my study and knowledge.

minecraft
Guest

Very shortly this website will be famous amid all blogging people,
due to it’s fastidious articles or reviews

minecraft
Guest

Good way of describing, and fastidious article to
get information on the topic of my presentation subject matter, which i am going to convey in institution of higher education.

minecraft
Guest

Oh my goodness! Incredible article dude! Thank you, However I am encountering problems with your RSS.
I don’t understand why I am unable to subscribe to it. Is there anybody else getting the same RSS issues?
Anyone who knows the solution can you kindly
respond? Thanks!!

minecraft
Guest

I do not know if it’s just me or if perhaps
everybody else encountering issues with your site.
It seems like some of the written text on your content are running off
the screen. Can someone else please provide feedback and let me know if
this is happening to them as well? This may be a
problem with my web browser because I’ve had this happen previously.
Kudos

minecraft
Guest

Everything composed was actually very reasonable. However,
what about this? suppose you were to write a awesome title?
I ain’t saying your content is not solid.,
but what if you added a post title that makes people desire more?

I mean Abatacept (Orencia): Plattenepithelkarzinome,
Hautpapillome, Lymphome und maligne Neoplasmen der Lunge | thasso is kinda vanilla.

You might glance at Yahoo’s front page and see how they create news titles to grab viewers interested.
You might add a video or a related pic or two to grab people interested about what you’ve got to say.
In my opinion, it might make your posts a little livelier.

minecraft
Guest

I could not refrain from commenting. Exceptionally well written!

minecraft
Guest

I am really thankful to the owner of this website who has shared this enormous post at at this place.

minecraft
Guest

It’s really a great and useful piece of information. I am satisfied
that you shared this helpful information with us. Please stay us informed like this.
Thank you for sharing.

Treffen
Guest

Toll gemachte Website, das Layout gefaellt mir sehr gut!
War sicher ne menge Arbeit.

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • How much sunshine causes melanoma? It's in your genes November 21, 2019
    Australian researchers from QIMR Berghofer Medical Research Institute have shown that 22 different genes help to determine how much sun exposure a person needs to receive before developing melanoma.
  • You can test your embryos for genetic defects, but designer babies aren't here just yet November 21, 2019
    Designer baby, anyone? A New Jersey startup company, Genomic Prediction, might be able to help you.
  • Researchers identify a molecular mechanism involved in Huntington's disease November 21, 2019
    Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease. These results, published in […]
  • New Alzheimer risk gene discovered November 21, 2019
    A new paper in the Journal of Neuropathology & Experimental Neurology finds a gene that may help explain a large part of the genetic risk for developing Alzheimer disease.
  • Team publishes findings on TAF1 syndrome November 21, 2019
    An international, multidisciplinary research team from more than 50 institutions, led by geneticist and psychiatrist Gholson Lyon, MD, Ph.D., of the New York State Office for People With Developmental Disabilities' (OPWDD) Institute for Basic Research in Developmental Disabilities (IBR), today announced publication of findings from its study of the rare disease TAF1 syndrome.
Top